Literature DB >> 1921146

Acanthocyturia--a characteristic marker for glomerular bleeding.

H Köhler1, E Wandel, B Brunck.   

Abstract

Erythrocyte morphology by phase contrast microscopic examination (PCM) of the urine is widely employed in distinguishing glomerular from nonglomerular bleeding. The proposed percentages of dysmorphic red cells are significant for glomerular bleeding in the range of 10 to 80% in the literature, because there is no clear cut definition of "dysmorphism." In the present study midstream urine samples of 351 patients with hematuria (greater than 8 erythrocytes/microliters) and of 33 healthy controls were examined. The various dysmorphic red cells were analyzed by PCM according to a detailed hematological classification. Most of the dysmorphic red cells, such as echinocytes, anulocytes, ghost cells, schizocytes, stomatocytes, codocytes and knizocytes, occurred in glomerular or nonglomerular disease as well, and proved to be uncharacteristic for glomerular bleeding. In contrast, a unique red cell deformity, a ringform with vesicle-shaped protrusions (acanthocyte) closely correlated to glomerular disease. In biopsy proven glomerulonephritis acanthocytes comprised 12.4% of all excreted red cells, whereas in nonglomerular diseases or in healthy subjects acanthocytes were seen very rarely (less than 2%) or not at all. Acanthocyturia greater than or equal to 5% (of excreted red cells) was seen in 75 out of 143 patients with proven glomerulonephritis (sensitivity 52%) and in four out of 187 patients with nonglomerular disease (specificity 98%). To improve the diagnostic value of erythrocyte morphology the diagnostic workup should focus on acanthocyturia, which is also indicative in very low erythrocyte counts.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1921146     DOI: 10.1038/ki.1991.188

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  30 in total

1.  [Microhaematuria. Clarification: when and how?].

Authors:  G H Heine; H Köhler
Journal:  Urologe A       Date:  2003-04       Impact factor: 0.639

Review 2.  Differential diagnosis of glomerular disease: a systematic and inclusive approach.

Authors:  Lee A Hebert; Samir Parikh; Jason Prosek; Tibor Nadasdy; Brad H Rovin
Journal:  Am J Nephrol       Date:  2013-09-13       Impact factor: 3.754

3.  Glomerular isolated microscopic hematuria: urinary features and long term follow-up of a selected cohort of patients.

Authors:  Cecilia Bellincioni; Giuseppe Garigali; Giovanni B Fogazzi
Journal:  J Nephrol       Date:  2018-12-10       Impact factor: 3.902

4.  A useful new classification of dysmorphic urinary erythrocytes.

Authors:  Daisuke Nagahama; Kenichi Yoshiko; Mikio Watanabe; Yoshiki Morita; Yoshinori Iwatani; Seiichi Matsuo
Journal:  Clin Exp Nephrol       Date:  2005-12       Impact factor: 2.801

5.  Evidence-based practice guideline for the treatment of CKD.

Authors: 
Journal:  Clin Exp Nephrol       Date:  2009-12       Impact factor: 2.801

6.  Dynamics of red blood cells in microporous membranes.

Authors:  Justyna Czerwinska; Michael Rieger; Dominik E Uehlinger
Journal:  Biomicrofluidics       Date:  2014-07-02       Impact factor: 2.800

Review 7.  Nephrology, dialysis and transplantation.

Authors:  K Farrington; P Sweny
Journal:  Postgrad Med J       Date:  1993-07       Impact factor: 2.401

Review 8.  The Investigation of Hematuria.

Authors:  Christian Bolenz; Bernd Schröppel; Andreas Eisenhardt; Bernd J Schmitz-Dräger; Marc-Oliver Grimm
Journal:  Dtsch Arztebl Int       Date:  2018-11-30       Impact factor: 5.594

Review 9.  [Renal manifestations of rheumatic diseases].

Authors:  A Schwarting; E Märker-Hermann
Journal:  Z Rheumatol       Date:  2005-02       Impact factor: 1.372

Review 10.  [Hematuria in cases of bladder cancer].

Authors:  F Wawroschek; S Roth
Journal:  Urologe A       Date:  2003-02-25       Impact factor: 0.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.